Overview

Pharmacokinetics Study of Liposomal Paclitaxel in Humans

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether there is any difference of the pharmacokinetics of two taxane formulations, paclitaxel injection and liposomal paclitaxel in Chinese cancer patients with solid tumors.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong Luye Pharmaceutical Co., Ltd.
Collaborator:
Nanjing Sike Pharmaceutical Co., Ltd.
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel